Clinical Trial 45964

Garden Grove, CA 92845


Summary:

This Phase 2, double-blind, placebo-controlled, randomized study is to assess the safety and efficacy of miricorilant (CORT118335) in obese patients with schizophrenia treated with antipsychotic medications.



Criteria:
  • Have a diagnosis of schizophrenia
  • Are currently taking olanzapine, risperidone, paliperidone, or quetiapine and have gained weight from treatment while on these medications
  • Must be on a stable dose of medication for 1 month prior to screening
  • Have a BMI ≥30 kg/m2


Qualified Participants May Receive:

Monetary compensation for participating.


Available At:

Collaborative Neuroscience Research, LLC

Garden Grove, CA 92845
View Clinic Location

 


If you or someone you care for is interested in participating and lives within 50 miles of the location shown, please complete the form below and click 'Submit'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.